Pacira Q2 FY26 returns to GAAP profit of USD 4.7 million; revenue rises 6% to USD 192.4 million - PCRX News | RalliesPacira Q2 FY26 returns to GAAP profit of USD 4.7 million; revenue rises 6% to USD 192.4 million
P
PCRX• Q2 results and outlook
- Pacira posted Q2 GAAP net income of USD 4.7 million, or USD 0.12 per share, swinging from a year-earlier loss.
- Revenue rose 6% year over year to USD 192.4 million, led by EXPAREL at USD 147.8 million, up 3%.
- Adjusted EBITDA fell 10% to USD 48.7 million; non-GAAP net income declined 18.02% to USD 29.5 million.
- Closed iovera° divestiture to Zimmer Biomet for up to USD 140 million, including USD 70 million upfront; received USD 73.6 million cash.
- Cut 2026 revenue outlook to USD 735 million-USD 760 million; reiterated EXPAREL sales view of USD 600 million-USD 620 million.
